Lugano, Switzerland/Sandpoint, ID (ots) - Helsinn Group makes an equity investment for a minority interest in Thorne Research, Inc. and plans to jointly commercialize nutritional supplement products with initial focus on meeting the needs of people living with cancer Helsinn Group a rapidly growing pharmaceutical ...
Contact: Sensus Investor and Public Relations GmbH, Zürich: Tel +41 43 366 55 11 | Fax +41 43 366 55 12 Email lifewatch@sensus.ch Branche: Healthcare Providers ISIN: CH0012815459 WKN: 1281545 Index: SPI, SPIEX Börsen: Frankfurt / Open Market / XETRA Berlin / free trade SIX Swiss Exchange / Main Standard ...
Contact: Sensus Investor and Public Relations GmbH, Zürich: Tel +41 43 366 55 11 | Fax +41 43 366 55 12 Email lifewatch@sensus.ch Branche: Healthcare Providers ISIN: CH0012815459 WKN: 1281545 Index: SPI, SPIEX Börsen: Frankfurt / Open Market / ...
Contact: Sensus Investor and Public Relations, Zürich: Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch Branche: Healthcare Providers ISIN: CH0012815459 WKN: 1281545 Index: SPI, SPIEX Börsen: Frankfurt / Open Market / XETRA Berlin / free trade SIX Swiss Exchange / Main Standard ...
Contact: Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG: Tel +41 52 632 00 50 | Fax +41 52 632 00 51; Email kobibe@lifewatch.com Sensus Investor and Public Relations GmbH, Zürich: Tel +41 43 366 55 11 | Fax +41 43 366 55 12; Email lifewatch@sensus.ch Branche: Healthcare Providers ISIN: CH0012815459 WKN: 1281545 Index: SPI, SPIEX Börsen: Frankfurt / Open Market / XETRA Berlin / free trade SIX Swiss Exchange / ...
Contact: Sensus Investor & Public Relations, Zürich: Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.ch Branche: Healthcare Providers ISIN: CH0012815459 WKN: 1281545 Index: SPI, SPIEX Börsen: Frankfurt / Open Market / XETRA Berlin / free trade SIX Swiss Exchange / Main Standard ...
Contact: Sensus Investor & Public Relations, Zürich: Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail: lifewatch@sensus.ch Branche: Healthcare Providers ISIN: CH0012815459 WKN: 1281545 Index: SPI, SPIEX Börsen: Frankfurt / Open Market / XETRA Berlin / free trade SIX Swiss Exchange / Main Standard ...
Freising, Germany (ots) - Pieris AG announced today the upcoming presentation of new preclinical and interim Phase I clinical trial data for its PRS-050 Anticalin( program, currently under evaluation for the treatment of cancer. Dr. Laurent Audoly, Chief Scientific Officer of Pieris, will speak on Friday, February ...
Contact: Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch Tel +1 847 813 4299 | Fax +1 847 813 2448 | E-mail: wkim@lifewatch.com Sensus Investor & Public Relations, Zürich: Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information/LifeWatch AG 09.02.2011 Neuhausen am Rheinfall/Switzerland - ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information/Capital reduction 02.02.2011 Neuhausen am Rheinfall / ...
St. Gallen Oncology Conferences (SONK)
St. Gallen (ots) - This bi-annual conference will highlight meaningful advances concerning treatment of Early Breast Cancer (EBC). The conference will build up on earlier diagnostic and therapeutic recommendations and thereafter provide written guidelines for the international community. Breast cancer specialists from all over the world are awaiting these new ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information/LifeWatch AG 11.11.2010 Neuhausen am Rheinfall / Switzerland - The shareholders of LifeWatch AG (SIX Swiss ...
Ittigen, Berne (ots) - Pevion Biotech AG today announced positive preliminary results from a Phase I study of PEV7, the first vaccine against recurrent vulvovaginal candidiasis (RVVC). Also known as chronic recurrent thrush, RVVC is a highly debilitating condition, which affects an estimated 3-6% of women ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information/Disclosure 08.11.2010 Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE), the leading provider of wireless telemedicine, announced today that LifeWatch ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information/LifeWatch AG 08.11.2010 Neuhausen am Rheinfall / Switzerland ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 3-month report/LifeWatch Q3 2010 Results 03.11.2010 LifeWatch reports loss for ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 3-month report/Q3 2010 Results 21.10.2010 - Press release at 7:00 a.m. CET; - ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 18.10.2010 LifeWatch AG plans a par value reduction, returning the means thus made available to the shareholders in February 2011 * Extraordinary ...
Zurich (ots) - Solianis Monitoring Ltd reaches another milestone testing their Multisensor Glucose Monitoring System for non-invasive continuous glucose monitoring in daily life The latest generation of Solianis' Multisensor Glucose Monitoring System with the final sensor configuration was tested in ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 22.09.2010 Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE), the leading provider of wireless telemedicine, ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information 16.09.2010 Stephen J. Zielinski appointed Senior Vice President of Sales of LifeWatch Corp. Neuhausen am Rheinfall/ Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE) ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 3-month report/LifeWatch AG 29.07.2010 Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE), the leading wireless remote cardiac and medical patient monitoring service ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 6-month report/LifeWatch AG 19.07.2010 - 07:00 a.m. CEST: Press release/Letter to Shareholders; - 10:00 a.m. CEST: Analyst/Media Conference; ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information/Disclosure of equity participations 08.07.2010 Henderson Global Investors take significant stake in LifeWatch AG Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 6-month report/LifeWatch AG 01.07.2010 - Press release at 7:00 a.m. CEST. - Analyst and media conference held in Zurich at 10:00 a.m. CEST. - International Live Conference Call/Web cast at 10:00 a.m. ...
Freising-Weihenstephan (ots) - Pieris AG announced today that Laurent Audoly, Ph.D., has joined the company as Chief Scientific Officer, effective immediately. Dr. Audoly, most recently Biologics Research Site Lead at Merck & Co. Inc., brings both pharma and biotech experience, with extensive expertise in therapeutic protein drug development. "Laurent has an impressive track record of leading teams and ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information/LifeWatch AG 26.05.2010 Shareholders approve all proposals of the Board of Directors Gregory Henry Volkart, Dr. Abraham Sartani and Urs Wettstein re-elected as members of the Board for a one-year term of office National ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. New Products/LifeWatch AG 11.05.2010 Chicago, IL / USA May 11 2010 -LifeWatch Services, Inc., a subsidiary of LifeWatch AG (SIX Swiss Exchange: LIFE), will announce the launch of their remote ECG ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. New Products/LifeWatch AG 11.05.2010 First in Series of Treatment-Specific Remote Patient Monitoring Services Chicago, IL / USA May 11 2010 - LifeWatch Services, Inc., a subsidiary of LifeWatch AG (SIX Swiss Exchange: LIFE), will unveil its advanced ...